Our Board
Our Board has a wealth of industry experience including clinical and scientific expertise across the radiopharmaceutical, molecular imaging, diagnostics, and medical technology sectors.
Between them, they have led the development, launch, and successful commercialisation of radiopharmaceuticals, for many of the industry’s leading global players.
David Hail
Chairman
Over 30 years’ experience within and consulting to the pharmaceutical, healthcare and molecular imaging industries at Senior Executive and Board level.
Paul Cload, PhD
Director
Over 30 years’ experience in the pharmaceutical, medical device and diagnostics industries having held senior, global positions in clinical development and strategic/tactical marketing with the Wellcome Research Laboratories, Amersham Health, GE Healthcare and a medical imaging start-up.
James McCutcheon, FCCA
Director
James is a highly experienced commercial and finance director with over 30 years’ experience in the pharmaceutical and medical device sectors, having held senior finance positions in both large multinationals, as well as smaller fast growing SMEs.
Mark Rosser, PhD
Director
Mark has been working on the development of products for nuclear medicine since 1994, with experiences covering manufacturing and supply through clinical development and regulatory submissions. A co-founder of Serac Imaging Systems and Serac Healthcare, Mark has been CEO of Serac Imaging Systems since 2021.
Pat Butler
Board Observer and Advisor
Pat is a director of Hikma Pharmaceuticals, Chairman of Aldermore Bank, was formerly a Senior Director at McKinsey & Co., and is a qualified chartered accountant. He is also a Governor of the British Film Institute and a trustee of the Resolution Foundation.
